BIOREGENX, INC. (BRGX)
BioRegenx, Inc. develops, manufactures, and sells medical test equipment, science-based nutritional products, and AI-driven health monitoring technologies. Its products include the GlycoCheck system for microvascular health assessment, the Endocalyx Pro dietary supplement, and the DocSun AI engine for contactless vital sign monitoring. The company focuses on regenerative biotherapeutics, anti-aging, and non-invasive medical and wellness devices.
Sector: Services-Computer Programming, Data Processing, Etc.
Industry: Medical - Instruments & Supplies
BioRegenx, Inc.
OTC:BRGXTechnology · Information Technology Services
$0.0002
Mkt Cap$194K
Float322.23M
O/S971.58M
Inst Own-
SI0.1%
Dilution
MCap$194K
Float322.23M
O/S971.58M
Dilution